New approach to insulin treatment improves patients' lives

October 03, 2002

Training patients with diabetes to adjust their insulin doses to match their food choices, improves diabetes control and quality of life, finds a study in this week's BMJ.

This approach has been developed in Germany, but has not been widely adopted elsewhere. Patients in the UK often have impaired quality of life and a high risk of diabetic complications. Researchers in Sheffield, London and North Tyneside set out to test this approach in the UK with the dose adjustment for normal eating (DAFNE) trial.

They identified 169 adults with type 1 diabetes attending hospital clinics in Sheffield, Northumbria, and London. Patients either attended a five day training course, or continued to receive usual care for six months as controls and then attend a course.

The course trained patients to adjust their insulin doses to match their food choices, rather than being expected to sacrifice dietary preferences to fit in with prescribed insulin doses. Participants in DAFNE had improved glycaemic control and, despite intensified insulin treatment, reported greater satisfaction with treatment, general wellbeing, and quality of life.

The personal importance of these improvements are illustrated by patient's comments. One said, "I now feel able to travel abroad without worry about not eating or eating on time." Another said, "I have found my whole lifestyle and outlook on life has improved."

Skills training enables patients to fit diabetes into their lives rather than their lives into diabetes, and can be applied successfully across different healthcare systems, say the authors. This approach has the potential to enable more people to adopt intensive insulin treatment and is worthy of further investigation, they conclude.
-end-


BMJ

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.